# Dysregulated vitamin D signaling in Hashimoto’s thyroiditis: an integrated transcriptomic study in a Korean cohort

**Authors:** Dong-Woo Lim, Ho-Jung Jeong, Jin Seok Lee, Min-Seo Choi, Sungsoon Fang, Jing-Hua Wang, Hojun Kim, Seok-Mo Kim

PMC · DOI: 10.3389/fendo.2025.1666115 · Frontiers in Endocrinology · 2025-10-03

## TL;DR

This study finds that vitamin D signaling is dysregulated in Hashimoto’s thyroiditis, with lower serum vitamin D levels and higher gene activity in thyroid tissues from Korean patients.

## Contribution

The study provides RNA-seq evidence of dysregulated vitamin D signaling in thyroid tissues of Hashimoto’s thyroiditis patients.

## Key findings

- Serum vitamin D levels were significantly lower in Hashimoto’s thyroiditis patients.
- Vitamin D receptor and related genes were upregulated in thyroid tissues of HT patients.
- RNA-seq and pathway analysis revealed complex vitamin D signaling dysregulation in HT.

## Abstract

Hashimoto’s thyroiditis (HT) is the most common thyroid disease leading to hypothyroidism in developed countries. Recent studies have highlighted vitamin D as a potential risk factor or therapeutic agent for HT owing to its role in modulating immune responses, although concrete evidence has not been presented. This retrospective observational study was conducted to investigate serum vitamin D levels and dysregulation of vitamin D signaling pathways in patients with HT.

Patients who underwent thyroid surgery for various thyroid neoplasm with or without HT were recruited. We analyzed serum thyroid biomarkers, including serum vitamin D, anti-thyroglobulin (TG) antibody, and anti-thyroid peroxidase (TPO) antibody for patients with HT. Using RNA-seq, the gene expression profile of thyroid tissue and the potential correlation between HT and vitamin D levels or its signaling were investigated.

The serum vitamin D levels were significantly lower in patients with HT. However, vitamin D receptor (VDR) expression and genes involved in vitamin D-associated biological process (BP) were significantly upregulated in the HT group. Visualization of expression profile on Wikipathways revealed multifaceted regulation of vitamin D-related pathways in the HT group. Real-time PCR and immunofluorescence staining confirmed enhanced VDR expression in thyroid tissues from the HT cohort.

Our study presents RNA-seq data acquired from the Korean HT cohort in this study, and highlighted dysregulated vitamin D signaling in thyroid tissues from the HT cohort. Further investigations are needed to elucidate the causal role of vitamin D signaling in the pathogenesis of HT.

## Linked entities

- **Genes:** VDR (vitamin D receptor) [NCBI Gene 7421]
- **Diseases:** Hashimoto’s thyroiditis (MONDO:0007699)

## Full-text entities

- **Genes:** TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}, TG (thyroglobulin) [NCBI Gene 7038] {aka AITD3, TGN}
- **Diseases:** thyroid disease (MESH:D013959), hypothyroidism (MESH:D007037), HT (MESH:D050031), thyroid neoplasm (MESH:D013964)
- **Chemicals:** vitamin D (MESH:D014807)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12532006/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12532006/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12532006/full.md

---
Source: https://tomesphere.com/paper/PMC12532006